D.A. Davidson & Co.
- SEC CIK
- 0001080107
- Latest filing
- Jul 24, 2026
SPRO holding history
Spero Therapeutics, Inc. in every 13F filed by D.A. Davidson & Co., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SPRO overviewAll 13F holders of SPROFull Q2 2026 holdings
- Shares (Q3 2022)
- 0
- Sold out in Q3 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 6
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2022 | 0 | $0 | 0.0% | −10,800−100.0% | Sold out | Holders |
| Q2 2022 | 10,800 | $8.00K | <0.1% | −33,000−75.3% | Reduced | Holders |
| Q1 2022 | 43,800 | $381.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2021 | 43,800 | $701.0K | <0.1% | +800+1.9% | Added | Holders |
| Q3 2021 | 43,000 | $792.0K | <0.1% | +9,000+26.5% | Added | Holders |
| Q2 2021 | 34,000 | $475.0K | <0.1% | +500+1.5% | Added | Holders |
| Q1 2021 | 33,500 | $493.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.